Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.6% over the forecast period 2023-2030. Neurology clinical trials are scientific studies conducted in humans to evaluate the safety and efficacy of new treatments, drugs, devices, or diagnostic procedures for neurological conditions. Neurological conditions are disorders that affect the brain, spinal cord and nerves that control movement, sensation, thinking, and behavior. The Neurology Clinical Trials Market is expanding because of factors such as the rising increasing prevalence of neurological diseases such as Alzheimer’s disease, epilepsy, and stroke and a growing number of clinical trials and research activities.
The growing prevalence of neurological disorders across the globe is fostering market growth. According to a report from Alzheimer Disease International Organization, in the year 2020, globally there were around 55 million people suffering from dementia and this figure is expected to reach 78 million in the year 2030 and 139 million by the year 2050. Furthermore, the rising number of neurological clinical trials activities is further driving the market growth, According to the Alzheimer's Association article 'Alzheimer's Disease Drug Development Pipeline: 2021', There were 121 drugs in clinical trials to treat Alzheimer's disease, 39 Phase 3 trials are using 29 agents, 73 Phase 2 trials involving 65 agents, and 27 Phase 1 trial including 27 agents. Twelve medicines are now undergoing clinical trials with the goal of improving cognition, and 12 others are meant to treat behavioral and neuropsychiatric problems. As of February 2020, 97 drugs were undergoing studies to modify illness. Along with these, ClinicalTrials.gov reports that as of June 2022, there are 1,755 epilepsy studies in progress. Thus, the rising number of clinical trials activities is driving the market growth. In Addition, increasing funding for neurological studies by public organizations and a significant number of CROs providing neurology clinical research services is creating a lucrative opportunity for the market. However, the high cost of Neurology Clinical Trials stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Neurology Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising FDA approvals for clinical trials, and the rising prevalence of neurological disorders in the region. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising prevalence of neurological conditions, an increase in the number of collaborations for clinical trials, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals)
AstraZeneca
Novartis AG
Eisai Co., Ltd.
Eli Lilly and Company
Aurora Health Care
AbbVie Inc.
Zydus Group
Athira Pharma, Inc.
Annovis Bio Inc.
Recent Developments in the Market:
In January 2023, Biogen Inc. entered into an agreement with Alcyone Therapeutics (Alcyone) to develop Alcyone’s ThecaFlex DRx™ System, an implantable medical device for the subcutaneous delivery of antisense oligonucleotide (ASO) therapeutics into the intrathecal space. Through this agreement, Biogen intends to make better use of the ThecaFlex DRxTM System to increase accessibility and the patient treatment experience for a larger population of people with neurological disorders such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
In April 2022, Labcorp, announced the collaboration with Xcell Biosciences. The agreement states that Labcorp and Xcellbio will work together on initiatives to increase the effectiveness and security of cell and gene therapies for conditions such as Parkinson's disease, cancer, and other illnesses.
Global Neurology Clinical Trials Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Phase, Study Design, Indication, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Phaseofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Phase:
Phase I
Phase II
Phase III
Phase IV
By Study Design:
Interventional
Observational
Expanded Access
By Indication:
Epilepsy
Parkinson's Disease (PD)
Huntington's Disease
Stroke
Traumatic Brain Injury (TBI)
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
The growing prevalence of neurological disorders across the globe is fostering market growth. According to a report from Alzheimer Disease International Organization, in the year 2020, globally there were around 55 million people suffering from dementia and this figure is expected to reach 78 million in the year 2030 and 139 million by the year 2050. Furthermore, the rising number of neurological clinical trials activities is further driving the market growth, According to the Alzheimer's Association article 'Alzheimer's Disease Drug Development Pipeline: 2021', There were 121 drugs in clinical trials to treat Alzheimer's disease, 39 Phase 3 trials are using 29 agents, 73 Phase 2 trials involving 65 agents, and 27 Phase 1 trial including 27 agents. Twelve medicines are now undergoing clinical trials with the goal of improving cognition, and 12 others are meant to treat behavioral and neuropsychiatric problems. As of February 2020, 97 drugs were undergoing studies to modify illness. Along with these, ClinicalTrials.gov reports that as of June 2022, there are 1,755 epilepsy studies in progress. Thus, the rising number of clinical trials activities is driving the market growth. In Addition, increasing funding for neurological studies by public organizations and a significant number of CROs providing neurology clinical research services is creating a lucrative opportunity for the market. However, the high cost of Neurology Clinical Trials stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Neurology Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising FDA approvals for clinical trials, and the rising prevalence of neurological disorders in the region. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising prevalence of neurological conditions, an increase in the number of collaborations for clinical trials, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals)
AstraZeneca
Novartis AG
Eisai Co., Ltd.
Eli Lilly and Company
Aurora Health Care
AbbVie Inc.
Zydus Group
Athira Pharma, Inc.
Annovis Bio Inc.
Recent Developments in the Market:
In January 2023, Biogen Inc. entered into an agreement with Alcyone Therapeutics (Alcyone) to develop Alcyone’s ThecaFlex DRx™ System, an implantable medical device for the subcutaneous delivery of antisense oligonucleotide (ASO) therapeutics into the intrathecal space. Through this agreement, Biogen intends to make better use of the ThecaFlex DRxTM System to increase accessibility and the patient treatment experience for a larger population of people with neurological disorders such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
In April 2022, Labcorp, announced the collaboration with Xcell Biosciences. The agreement states that Labcorp and Xcellbio will work together on initiatives to increase the effectiveness and security of cell and gene therapies for conditions such as Parkinson's disease, cancer, and other illnesses.
Global Neurology Clinical Trials Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Phase, Study Design, Indication, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Phaseofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Phase:
Phase I
Phase II
Phase III
Phase IV
By Study Design:
Interventional
Observational
Expanded Access
By Indication:
Epilepsy
Parkinson's Disease (PD)
Huntington's Disease
Stroke
Traumatic Brain Injury (TBI)
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Neurology Clinical Trials Market, by Region, 2020-2030 (USD Billion)
1.2.2. Neurology Clinical Trials Market, by Phase, 2020-2030 (USD Billion)
1.2.3. Neurology Clinical Trials Market, by Study Design, 2020-2030 (USD Billion)
1.2.4. Neurology Clinical Trials Market, by Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET DYNAMICS
3.1. Neurology Clinical Trials Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of neurological diseases such as Alzheimer’s disease, epilepsy, and stroke
3.1.1.2. Growing number of clinical trials and research activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Neurology Clinical Trials
3.1.3. Market Opportunities
3.1.3.1. Increasing funding for neurological studies by public organizations
3.1.3.2. Significant number of CROs providing neurology clinical research services
CHAPTER 4. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, BY PHASE
5.1. Market Snapshot
5.2. Global Neurology Clinical Trials Market by Phase, Performance - Potential Analysis
5.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Phase 2020-2030 (USD Billion)
5.4. Neurology Clinical Trials Market, Sub Segment Analysis
5.4.1. Phase I
5.4.2. Phase II
5.4.3. Phase III
5.4.4. Phase IV
CHAPTER 6. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, BY STUDY DESIGN
6.1. Market Snapshot
6.2. Global Neurology Clinical Trials Market by Study Design, Performance - Potential Analysis
6.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Study Design 2020-2030 (USD Billion)
6.4. Neurology Clinical Trials Market, Sub Segment Analysis
6.4.1. Interventional
6.4.2. Observational
6.4.3. Expanded Access
CHAPTER 7. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, BY INDICATION
7.1. Market Snapshot
7.2. Global Neurology Clinical Trials Market by Indication, Performance - Potential Analysis
7.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
7.4. Neurology Clinical Trials Market, Sub Segment Analysis
7.4.1. Epilepsy
7.4.2. Parkinson's Disease (PD)
7.4.3. Huntington's Disease
7.4.4. Stroke
7.4.5. Traumatic Brain Injury (TBI)
7.4.6. Others
CHAPTER 8. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Neurology Clinical Trials Market, Regional Market Snapshot
8.4. North America Neurology Clinical Trials Market
8.4.1. U.S. Neurology Clinical Trials Market
8.4.1.1. Phase breakdown estimates & forecasts, 2020-2030
8.4.1.2. Study Design breakdown estimates & forecasts, 2020-2030
8.4.1.3. Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Neurology Clinical Trials Market
8.5. Europe Neurology Clinical Trials Market Snapshot
8.5.1. U.K. Neurology Clinical Trials Market
8.5.2. Germany Neurology Clinical Trials Market
8.5.3. France Neurology Clinical Trials Market
8.5.4. Spain Neurology Clinical Trials Market
8.5.5. Italy Neurology Clinical Trials Market
8.5.6. Rest of Europe Neurology Clinical Trials Market
8.6. Asia-Pacific Neurology Clinical Trials Market Snapshot
8.6.1. China Neurology Clinical Trials Market
8.6.2. India Neurology Clinical Trials Market
8.6.3. Japan Neurology Clinical Trials Market
8.6.4. Australia Neurology Clinical Trials Market
8.6.5. South Korea Neurology Clinical Trials Market
8.6.6. Rest of Asia Pacific Neurology Clinical Trials Market
8.7. Latin America Neurology Clinical Trials Market Snapshot
8.7.1. Brazil Neurology Clinical Trials Market
8.7.2. Mexico Neurology Clinical Trials Market
8.8. Middle East & Africa Neurology Clinical Trials Market
8.8.1. Saudi Arabia Neurology Clinical Trials Market
8.8.2. South Africa Neurology Clinical Trials Market
8.8.3. Rest of Middle East & Africa Neurology Clinical Trials Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. AstraZeneca
9.3.3. Novartis AG
9.3.4. Eisai Co., Ltd.
9.3.5. Eli Lilly and Company
9.3.6. Aurora Health Care
9.3.7. AbbVie Inc.
9.3.8. Zydus Group
9.3.9. Athira Pharma, Inc.
9.3.10. Annovis Bio Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Neurology Clinical Trials Market, by Region, 2020-2030 (USD Billion)
1.2.2. Neurology Clinical Trials Market, by Phase, 2020-2030 (USD Billion)
1.2.3. Neurology Clinical Trials Market, by Study Design, 2020-2030 (USD Billion)
1.2.4. Neurology Clinical Trials Market, by Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET DYNAMICS
3.1. Neurology Clinical Trials Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of neurological diseases such as Alzheimer’s disease, epilepsy, and stroke
3.1.1.2. Growing number of clinical trials and research activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Neurology Clinical Trials
3.1.3. Market Opportunities
3.1.3.1. Increasing funding for neurological studies by public organizations
3.1.3.2. Significant number of CROs providing neurology clinical research services
CHAPTER 4. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, BY PHASE
5.1. Market Snapshot
5.2. Global Neurology Clinical Trials Market by Phase, Performance - Potential Analysis
5.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Phase 2020-2030 (USD Billion)
5.4. Neurology Clinical Trials Market, Sub Segment Analysis
5.4.1. Phase I
5.4.2. Phase II
5.4.3. Phase III
5.4.4. Phase IV
CHAPTER 6. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, BY STUDY DESIGN
6.1. Market Snapshot
6.2. Global Neurology Clinical Trials Market by Study Design, Performance - Potential Analysis
6.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Study Design 2020-2030 (USD Billion)
6.4. Neurology Clinical Trials Market, Sub Segment Analysis
6.4.1. Interventional
6.4.2. Observational
6.4.3. Expanded Access
CHAPTER 7. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, BY INDICATION
7.1. Market Snapshot
7.2. Global Neurology Clinical Trials Market by Indication, Performance - Potential Analysis
7.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
7.4. Neurology Clinical Trials Market, Sub Segment Analysis
7.4.1. Epilepsy
7.4.2. Parkinson's Disease (PD)
7.4.3. Huntington's Disease
7.4.4. Stroke
7.4.5. Traumatic Brain Injury (TBI)
7.4.6. Others
CHAPTER 8. GLOBAL NEUROLOGY CLINICAL TRIALS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Neurology Clinical Trials Market, Regional Market Snapshot
8.4. North America Neurology Clinical Trials Market
8.4.1. U.S. Neurology Clinical Trials Market
8.4.1.1. Phase breakdown estimates & forecasts, 2020-2030
8.4.1.2. Study Design breakdown estimates & forecasts, 2020-2030
8.4.1.3. Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Neurology Clinical Trials Market
8.5. Europe Neurology Clinical Trials Market Snapshot
8.5.1. U.K. Neurology Clinical Trials Market
8.5.2. Germany Neurology Clinical Trials Market
8.5.3. France Neurology Clinical Trials Market
8.5.4. Spain Neurology Clinical Trials Market
8.5.5. Italy Neurology Clinical Trials Market
8.5.6. Rest of Europe Neurology Clinical Trials Market
8.6. Asia-Pacific Neurology Clinical Trials Market Snapshot
8.6.1. China Neurology Clinical Trials Market
8.6.2. India Neurology Clinical Trials Market
8.6.3. Japan Neurology Clinical Trials Market
8.6.4. Australia Neurology Clinical Trials Market
8.6.5. South Korea Neurology Clinical Trials Market
8.6.6. Rest of Asia Pacific Neurology Clinical Trials Market
8.7. Latin America Neurology Clinical Trials Market Snapshot
8.7.1. Brazil Neurology Clinical Trials Market
8.7.2. Mexico Neurology Clinical Trials Market
8.8. Middle East & Africa Neurology Clinical Trials Market
8.8.1. Saudi Arabia Neurology Clinical Trials Market
8.8.2. South Africa Neurology Clinical Trials Market
8.8.3. Rest of Middle East & Africa Neurology Clinical Trials Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. AstraZeneca
9.3.3. Novartis AG
9.3.4. Eisai Co., Ltd.
9.3.5. Eli Lilly and Company
9.3.6. Aurora Health Care
9.3.7. AbbVie Inc.
9.3.8. Zydus Group
9.3.9. Athira Pharma, Inc.
9.3.10. Annovis Bio Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Neurology Clinical Trials Market, report scope
TABLE 2. Global Neurology Clinical Trials Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Neurology Clinical Trials Market estimates & forecasts by Phase 2020-2030 (USD Billion)
TABLE 4. Global Neurology Clinical Trials Market estimates & forecasts by Study Design 2020-2030 (USD Billion)
TABLE 5. Global Neurology Clinical Trials Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 6. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Neurology Clinical Trials Market
TABLE 71. List of primary sources, used in the study of global Neurology Clinical Trials Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Neurology Clinical Trials Market, report scope
TABLE 2. Global Neurology Clinical Trials Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Neurology Clinical Trials Market estimates & forecasts by Phase 2020-2030 (USD Billion)
TABLE 4. Global Neurology Clinical Trials Market estimates & forecasts by Study Design 2020-2030 (USD Billion)
TABLE 5. Global Neurology Clinical Trials Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 6. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Neurology Clinical Trials Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Neurology Clinical Trials Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Neurology Clinical Trials Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Neurology Clinical Trials Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Neurology Clinical Trials Market
TABLE 71. List of primary sources, used in the study of global Neurology Clinical Trials Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Neurology Clinical Trials Market, research methodology
FIG 2. Global Neurology Clinical Trials Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Neurology Clinical Trials Market, key trends 2022
FIG 5. Global Neurology Clinical Trials Market, growth prospects 2023-2030
FIG 6. Global Neurology Clinical Trials Market, porters 5 force model
FIG 7. Global Neurology Clinical Trials Market, pest analysis
FIG 8. Global Neurology Clinical Trials Market, value chain analysis
FIG 9. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Neurology Clinical Trials Market, regional snapshot 2020 & 2030
FIG 15. North America Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 16. Europe Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Neurology Clinical Trials Market, research methodology
FIG 2. Global Neurology Clinical Trials Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Neurology Clinical Trials Market, key trends 2022
FIG 5. Global Neurology Clinical Trials Market, growth prospects 2023-2030
FIG 6. Global Neurology Clinical Trials Market, porters 5 force model
FIG 7. Global Neurology Clinical Trials Market, pest analysis
FIG 8. Global Neurology Clinical Trials Market, value chain analysis
FIG 9. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Neurology Clinical Trials Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Neurology Clinical Trials Market, regional snapshot 2020 & 2030
FIG 15. North America Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 16. Europe Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Neurology Clinical Trials Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
